Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Popular Stock Has a 93% Upside, According to Wall Street

TheMotleyFool

0 0

This Popular Stock Has a 93% Upside, According to Wall Street

If you had invested in Novavax (NASDAQ: NVAX) at the beginning of 2020, you'd be sitting pretty right now. Shares of the biotech have skyrocketed by a whopping 3,340% in the past year and nine months. Novavax's efforts to develop and market a vaccine for COVID-19 explain the company's terrific performance of late.

That being said, there remains some healthy upside ahead for Novavax, at least according to Wall Street. The company's average price target of $264.20 implies gains of 93% from its share price of $136.86 as of this writing. Should investors heed Wall Street's advice and purchase shares of this popular biotech stock?